Survival Outcomes of Patients With Primary Plasma Cell Leukemia (pPCL) Treated With Novel Agents

Cancer - United States
doi 10.1002/cncr.31718
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Novel Hematological Biomarkers Predict Survival in Renal Cell Carcinoma Patients Treated With Nephrectomy

Archives of Medical Science
Medicine
2017English

Plasma Cell Leukemia- Light Chain Secretory Type, With Primary Amyloidosis

Journal of Evolution of Medical and Dental Sciences
2012English

The Effect of Targeted Agents on Outcomes in Patients With Brain Metastases From Renal Cell Carcinoma Treated With Gamma Knife Surgery

Journal of Neurosurgery
SurgeryNeurology
2012English

Survival Benefit With Novel Agents in Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (Ptcl): The Columbia University Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated With Novel Agents as a Primary Therapy

American Journal of Hematology
Hematology
2017English

Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide

Clinical Journal of Oncology Nursing
Oncology
2010English

Clinical Outcomes of Patients With ACS Treated With Prasugrel

Heart Lung and Circulation
Respiratory MedicinePulmonaryCardiovascular MedicineCardiology
2013English

Long-Term Survival of Beta Thalassemia Major Patients Treated With Hematopoietic Stem Cell Transplantation Compared With Survival With Conventional Treatment

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy